Resources

From November 2023 through May 2025, perennial malaria chemoprevention was piloted in Kongo Central province in the Democratic Republic of the Congo for malaria prevention in children under two. These briefs summarize the lessons learned from pilot implementation, including areas such as integration into existing systems, supply management, and supervision.

From November 2023 through May 2025, perennial malaria chemoprevention was piloted in Kongo Central province in the Democratic Republic of the Congo for malaria prevention in children under two. These briefs summarize the lessons learned from pilot implementation, including areas such as integration into existing systems, supply management, and supervision.

Cold chain maintenance workshop report: PATH, along with JSI, Village Reach, and CHAI, supported a workshop for over 50 cold chain technicians from six countries to gather and share best practices, engage in peer-to-peer learning, and explore ways to use data for improved cold chain maintenance and decision-making. The workshop report and results from a six-month follow-up survey can be found below.

This slide provides a snapshot of the respiratory syncytial virus (RSV) vaccine and monoclonal antibody (mAb) technology landscape, in the effort to track the development of RSV vaccine and mAb candidates and provide a summary of the various vaccine approaches being worked on around the world.This snapshot pairs with the RSV and mAb Trial Tracker, which provides publicly available information on clinical trials of RSV candidate vaccines and mAbs intended for prevention.

This spreadsheet provides publicly available information on clinical trials of respiratory syncytial virus (RSV) candidate vaccines and monoclonal antibodies intended for prevention.Sources of information for these trials are clinicaltrials.gov; who.int/clinical-trials-registry-platform; clinicaltrialsregister.eu; and anzctr.org.au, which includes clinical trial registries from 17 countries.Some information is also obtained through contact with investigators, sponsors, and funders of vaccine trials. This spreadsheet pairs with the RSV Vaccine and mAb Snapshot, which provides a summary of the RSV vaccine and mAb candidates in development worldwide.